O-Arylmandelic acids as highly selective human PPAR α/γ agonists
- 16 October 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (19) , 3185-3190
- https://doi.org/10.1016/s0960-894x(03)00702-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patientsEuropean Journal of Clinical Investigation, 2001
- FarglitazarDrugs of the Future, 2001
- Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome XEuropean Journal of Clinical Investigation, 2000
- Bezafibrate reduces blood glucose in type 2 diabetes mellitusMetabolism, 2000
- Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitusDiabetes/Metabolism Research and Reviews, 2000
- Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patientsAtherosclerosis, 2000
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- (3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agentsBioorganic & Medicinal Chemistry Letters, 1999
- Effect of Bezafibrate on Metabolic Profiles in Non-Insulin-Dependent Diabetes MellitusJournal of Cardiovascular Pharmacology, 1990